Hepatitis B: From Disease to Prevention

Dear Colleagues,

Hepatitis B is a severe viral and infectious disease that is responsible for a large number of primary liver cancer cases, especially if acquired during the first year of life. The introduction of an effective vaccine against hepatitis B in the 1980s (plasma derived, then replaced by recombinant DNA technology) has made a drastic reduction in the number of cases worldwide possible, especially in the age groups most at risk. Particularly at risk are health care workers, due to the transmission of the virus via blood. The aim of this Special Issue is to convene all aspects of hepatitis B infection, such as those that follow:

1. pathogenesis of the disease with particular attention to the molecular aspects;
2. epidemiology of the infection in the world;
3. vaccination against hepatitis B: efficacy, side effects, diffusion, vaccination schedule (age of the vaccine, doses), whether or not it is mandatory and if yes, for which age groups or professions;
4. professions at risk;
5. factors influencing vaccine efficacy over time;
6. systematic reviews on the aspects listed above.

Prof. Dr. Andrea Trevisan
Dr. Chiara Bertoncello
Dr. Marco Fonzo
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Viruses is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.